MedTrace Logo

Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes

NCT01080157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 509

Last updated 2012-12-04

No results posted yet for this study

Summary

The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOUT DS is being developed to help doctors measure these substances in skin and possibly help doctors diagnose diabetes.

Conditions

Interventions

DEVICE

SCOUT DS measurement

Non-invasive 3-5 volar forearm scan

Sponsors & Collaborators

  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • John Maynard, MS · VeraLight, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01080157 on ClinicalTrials.gov